Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{149473,
        author = {Mahmad Awaiz M. Shaikh and Deepak A. Joshi and Vidyasagar Gali and Shyamlila B. Bavage and Nandkishor B. Bavage},
        title = {DEGRADATION PATHWAY OF PHARMACEUTICAL DOSAGE FORMS},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {6},
        number = {12},
        pages = {517-521},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=149473},
        abstract = {In the formulation of drug dosage forms, stability consideration for the active pharmaceutical ingredients (API) and the excipients is critical. This is because degradation process leads to loss of efficacy, making the drug in a specific packaging not to remain in the specified chemical, physical, microbiological, therapeutic and toxicological specifications. Guillory and Poust (2002), Barnes (2013).Therefore, understanding the degradation pathways in order to achieve stability of both the drug substance and drug products is a key quality goal. Porter (2013)},
        keywords = {},
        month = {},
        }